Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate that Custodiol-HTK is not inferior to cold
cardioplegic solution in patients undergoing cardiovascular surgery requiring cardioplegic
arrest.